MESA LABORATORIES INC CO

For the period ended Sep 30, 2024. Filed Nov 7, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2024 · Filed Nov 7, 2024

MLAB$127.82-0.3%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Operations

(in thousands, except per share data)

	Three Months Ended September 30,		Six Months Ended September 30,
	2024	2023	2024	2023
Revenues	$57,833	$53,165	$116,003	$103,810
Cost of revenues	22,378	21,056	43,299	40,518
Gross profit	35,455	32,109	72,704	63,292
Operating expense:
Selling	9,849	9,650	19,965	18,626
General and administrative	17,464	17,526	34,282	35,586
Research and development	4,634	4,993	9,369	9,804
Total operating expense	31,947	32,169	63,616	64,016
Operating income (loss)	3,508	(60)	9,088	(724)
Nonoperating expense:
Interest expense and amortization of debt issuance costs	3,018	905	5,860	1,953
(Gain) on extinguishment of convertible senior notes	-	-	(3,197)	-
Other (income) expense, net	(3,322)	360	(1,292)	(415)
Total nonoperating (income) expense, net	(304)	1,265	1,371	1,538
Earnings (loss) before income taxes	3,812	(1,325)	7,717	(2,262)
Income tax expense (benefit)	384	(95)	901	(483)
Net income (loss)	$3,428	$(1,230)	$6,816	$(1,779)
Earnings (loss) per share:
Basic	$0.63	$(0.23)	$1.26	$(0.33)
Diluted	$0.63	$(0.23)	$1.25	$(0.33)
Weighted-average common shares outstanding:
Basic	5,413	5,387	5,405	5,379
Diluted	5,471	5,387	5,448	5,379

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.